Acutaas Chemicals Limited has announced a meeting of its Board of Directors scheduled for April 30, 2026. The primary agenda includes the consideration and approval of the company’s audited standalone and consolidated financial results for the fourth quarter and the financial year ended March 31, 2026. Additionally, the board will evaluate a recommendation for a final dividend payout for the fiscal year 2025-26.
Upcoming Board Meeting Details
The management of Acutaas Chemicals Limited is set to convene on April 30, 2026, to review the company’s financial performance. This session is critical as it will cover the audited standalone and consolidated financial statements for both the Q4 period (January to March) and the entire financial year 2025-26.
Dividend Consideration
During the same meeting, the Board of Directors will discuss the potential declaration of a final dividend for the equity shareholders for the fiscal year 2025-26. Any recommendation made by the board will be subject to final approval by the shareholders during the company’s upcoming Annual General Meeting.
Trading Window Update
In accordance with internal governance protocols, the company has restricted trading in its shares for designated persons. The trading window, which has been closed since April 1, 2026, is scheduled to remain closed until May 2, 2026, in alignment with the mandatory 48-hour period following the public disclosure of the financial results. Normal trading activities are expected to resume on Monday, May 4, 2026.
Source: BSE
